SCM
IMMU

Southport Capital Management’s Immunomedics Inc IMMU Stock Holding History

Southport Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,000
Closed -$2K – 497
2016
Q2 		$2K Buy
+1,000
New +$3.34K ﹤0.01% 512

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Southport Capital Management's IMMU Position: Q3 2016 in Review

Southport Capital Management sold out of Immunomedics Inc (IMMU) in Q3 2016, closing a stake of 1,000 shares — an estimated $2K sold.

Southport Capital Management first reported a position in IMMU in Q2 2016 and held it in 1 quarter. The position peaked at $2K in Q2 2016. 101 funds tracked by Wall St. Rank hold IMMU as of Q3 2016.

  • Southport Capital Management reported no remaining Immunomedics Inc position as of Q3 2016 after selling out during the quarter.
  • Southport Capital Management sold 1,000 Immunomedics Inc shares in Q3 2016, an estimated $2K.
  • Southport Capital Management first reported a position in Immunomedics Inc in Q2 2016 and held it in 1 quarter.
  • Southport Capital Management's Immunomedics Inc position peaked at $2K in Q2 2016.
  • 101 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2016.

Based on Southport Capital Management's 13F filing for Q3 2016, filed 19 Oct 2016.